HAART treatement ranges from $21,600 per year to $54,000 per year depending on the program that the individual is on.
Lower ancillary costs
less toxicity
less side effects
less deviation from the program (HAART patients routinely miss doses)
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-